Latest Close
$3.14
Stock Hub
SIGA
SIGA Technologies Inc.
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. Use the sections below to move between chart, technical analysis, fundamentals, and news.
1y Change
-$4.63 (-59.57%)
Market Cap
$225,608,096.00
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Recommendation
none
52W Range
$2.83 to $9.45
Target Mean Price
Not available
Beta
0.89
Trailing P/E
Not available
Forward P/E
2.91
Price / Book
1.36
Company Overview
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. was incorporated in 1995 and is headquartered in New York, New York.